Where Clinical Data, Science & Evidence Transforms Women’s Health
Evidence, Data & Innovation
Dedicated to R&D and Clinical Trials providing evidence generation and innovation
This stage highlights the science behind women's health. From inclusive trial design and regulatory pathways to pharma startup partnerships and digital biomarkers, discover how research is closing the sex difference data gap and accelerating women’s health breakthroughs.
Who Should Attend
- Pharma & Biotech pipeline scouting and trial innovation
- Clinical trials professionals recruitment, endpoints, AI and digital biomarkers
- Clinicians evidence based updates
- Insurance providers reviewing data and evidence to inform policy and reimbursement
Key Topics
Focus: R&D, clinical trials, regulatory science, digital biomarkers, and evidence generation
- Inclusive clinical trial design and representation of women
- AI and digital biomarkers to accelerate trials and endpoints
- Regulatory pathways across FDA, EMA, and global approvals
- Pharma and startup collaborations for novel therapies and devices
- Evidence based clinical updates shaping adoption
- Real world evidence, post market surveillance, and outcome analytics
- Innovative recruitment and retention strategies for diverse populations
We believe in equitable healthcare. That’s why attendance is free for any medical officers and leaders within hospitals and healthcare systems, pharma, biotech, corporate enterprises and government officials.
See Our Fertility & Reproductive Health Stage
